Diseases, Conditions, Syndromes

Researchers move closer to new vaccine for killer TB

Scientists said Tuesday they are closing in on a new game-changing vaccine for tuberculosis, the world's deadliest infectious disease that claimed some 1.5 million lives last year.

Diseases, Conditions, Syndromes

12.6 million in U.S. could benefit from therapy to prevent active TB

(HealthDay)—An estimated 12.6 million persons in the United States could benefit from treatment to prevent active tuberculosis (TB), according to a report published in the October issue of Emerging Infectious Diseases, ...

Medical research

Xpert Ultra test for diagnosing TB now included in Cochrane Review

Tuberculosis (TB) causes more deaths globally than any other infectious disease and is a top 10 cause of death worldwide. Globally in 2017, of the estimated 10 million people with TB, 3.6 million were not reported to national ...

Diseases, Conditions, Syndromes

Guidelines updated for TB screening, treatment in health care workers

(HealthDay)—Guidelines have been updated for screening and treatment for tuberculosis (TB) infection among health care personnel, according to research published in the May 17 issue of the U.S. Centers for Disease Control ...

Diseases, Conditions, Syndromes

CDC: TB incidence declined slightly in United States in 2017

(HealthDay)—In 2017, tuberculosis (TB) incidence declined in the United States and modest progress was made toward global TB elimination, according to two studies published in the March 21 issue of the U.S. Centers for ...

Diseases, Conditions, Syndromes

TGen and ABL pursue global rollout of advanced TB test

In an important step toward eradicating tuberculosis (TB), the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has signed a licensing agreement with an international biomedical firm, Advanced ...

page 8 from 17